Naperville, IL -- (SBWIRE) -- 09/13/2013 -- Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Dry Eye Syndrome - UK Drug Forecast and Market Analysis to 2022 market report to its offering
PharmaPoint: Dry Eye Syndrome - UK Drug Forecast and Market Analysis to 2022
Summary
GlobalData has released its new Country report, PharmaPoint: Dry Eye Syndrome - UK Drug Forecast and Market Analysis to 2022. Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic.
The DES market in the UK is projected to grow substantially during the forecast period. During the forecast period, the primary growth driver of the DES market in the UK will be the launch of the EUs first prescription product for DES, as well as the rapidly increasing population of DES patients.
Scope
- Overview of the DES including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the UK including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the UK from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the UK DES market.
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for DES
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in the UK.
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/141494/pharmapoint-dry-eye-syndrome-uk-drug-forecast-and-market-analysis-to-2022.html